Efficiency and Safety of an Early Dose Adjustment of Ribavirin in Patients Infected With Hepatitis C Underexposed to the Drug and Treated With Peginterferon Ribavirin-Reference-Cited by-同舟云学术

Efficiency and Safety of an Early Dose Adjustment of Ribavirin in Patients Infected With Hepatitis C Underexposed to the Drug and Treated With Peginterferon Ribavirin

Published:2016-12 Issue:6 Volume:38 Page:684-692
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Loustaud-Ratti Véronique,Maynard Marianne,Thevenon Sylvie,Pradat Pierre,Rousseau Annick,Alain Sophie,Deny Paul,Gagnieu Marie-Claude,Tran Albert,Dao Thông,Silvain Christine,Lunel-Fabiani Françoise,Picard Nicolas,Zublena Irène,Marquet Pierre,Trepo Christian,

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference27 articles.

1. Therapy for hepatitis C—the costs of success;Hoofnagle;N Engl J Med.,2014

2. New antiviral therapies in the management of HCV infection;Farnik;Antivir Ther.,2012

3. Protease inhibitors for the treatment of chronic hepatitis C genotype-1 infection: the new standard of care;Pearlman;Lancet Infect Dis.,2012

4. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med.,2002

5. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose;Hadziyannis;Ann Intern Med.,2004

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics-Based Adjusted Versus Standard Dose of Ribavirin Does Not Improve Virologic Response Rates in Chronic Hepatitis C Genotype 4 Patients: A Randomized Controlled Trial;Journal of Interferon & Cytokine Research;2017-11

2. DHEA prevents ribavirin-induced anemia via inhibition of glucose-6-phosphate dehydrogenase;Antiviral Research;2017-10